DrugPatentWatch Database Preview
Drugs in Development Information for Dolastatin 10
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Dolastatin 10?
Dolastatin 10 is an investigational drug.
There have been 7 clinical trials for Dolastatin 10.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 1999.
The most common disease conditions in clinical trials are Leukemia, Sarcoma, and Waldenstrom Macroglobulinemia. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Mayo Clinic.
Summary for Dolastatin 10
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 51 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (1999-03-01) |
| Vendors | 14 |
Recent Clinical Trials for Dolastatin 10
| Title | Sponsor | Phase |
|---|---|---|
| Dolastatin 10 in Treating Patients With Advanced Kidney Cancer | National Cancer Institute (NCI) | Phase 2 |
| Dolastatin 10 in Treating Patients With Advanced Kidney Cancer | Mayo Clinic | Phase 2 |
| Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma | National Cancer Institute (NCI) | Phase 2 |
Clinical Trial Summary for Dolastatin 10
Top disease conditions for Dolastatin 10
Top clinical trial sponsors for Dolastatin 10
US Patents for Dolastatin 10
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
